SLAM
RYTM icon

Swiss Life Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Swiss Life Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
3,539
+198
+6% +$17.9K ﹤0.01% 1104
2026
Q1 		$291K Buy
3,341
+688
+26% +$66.9K ﹤0.01% 1134
2025
Q4 		$284K Buy
2,653
+192
+8% +$20.4K ﹤0.01% 1050
2025
Q3 		$249K Buy
+2,461
New +$228K ﹤0.01% 1014

Other funds holding RYTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Swiss Life Asset Management's RYTM Position: Q2 2026 in Review

Swiss Life Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 5.9% in Q2 2026, buying an estimated $17.9K and bringing the position to 3,539 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Swiss Life Asset Management first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Swiss Life Asset Management held 3,539 shares of Rhythm Pharmaceuticals worth $393K as of Q2 2026.
  • Swiss Life Asset Management bought 198 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $17.9K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1104 holding.
  • Swiss Life Asset Management first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.